From The Lab To The Clinic: Developing And Delivering The Next Generation Of Therapies To Patients In Need
Forbes Healthcare Summit
|
December 6, 2024
X min read
Forbes Healthcare Summit
|
December 6, 2024
Share on Social
More like this
Media
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Read Now
Press
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Read Now
